B. Riley Issues Positive Forecast for Varex Imaging Earnings

Varex Imaging Co. (NASDAQ:VREX - Free Report) - Stock analysts at B. Riley raised their Q2 2025 earnings per share (EPS) estimates for Varex Imaging in a research note issued on Friday, February 7th. B. Riley analyst K. Bauser now expects that the company will earn $0.13 per share for the quarter, up from their prior forecast of $0.07. B. Riley has a "Buy" rating and a $22.00 price objective on the stock. The consensus estimate for Varex Imaging's current full-year earnings is $0.63 per share. B. Riley also issued estimates for Varex Imaging's Q3 2025 earnings at $0.19 EPS and FY2026 earnings at $0.62 EPS.

Varex Imaging (NASDAQ:VREX - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The company reported $0.07 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.03. Varex Imaging had a negative net margin of 5.79% and a positive return on equity of 3.96%.

A number of other equities research analysts have also recently weighed in on the company. Oppenheimer cut their price objective on Varex Imaging from $30.00 to $23.00 and set an "outperform" rating for the company in a research report on Friday, February 7th. StockNews.com upgraded Varex Imaging from a "hold" rating to a "buy" rating in a research note on Friday, February 7th.

Varex Imaging Price Performance

Shares of NASDAQ:VREX traded up $0.17 during trading on Monday, reaching $13.61. The stock had a trading volume of 377,415 shares, compared to its average volume of 529,042. The stock has a market capitalization of $561.14 million, a PE ratio of -11.63 and a beta of 0.62. Varex Imaging has a 52 week low of $10.19 and a 52 week high of $18.30. The business's 50-day moving average price is $14.27 and its 200 day moving average price is $13.34. The company has a debt-to-equity ratio of 0.72, a current ratio of 3.32 and a quick ratio of 1.97.

Institutional Trading of Varex Imaging

Several hedge funds have recently modified their holdings of VREX. Pzena Investment Management LLC lifted its holdings in Varex Imaging by 51.4% during the 3rd quarter. Pzena Investment Management LLC now owns 3,890,879 shares of the company's stock worth $46,379,000 after buying an additional 1,321,666 shares in the last quarter. Wellington Management Group LLP bought a new stake in shares of Varex Imaging during the third quarter worth $19,801,000. Wealthfront Advisers LLC acquired a new position in shares of Varex Imaging during the fourth quarter valued at $18,900,000. Geode Capital Management LLC boosted its holdings in Varex Imaging by 0.5% in the third quarter. Geode Capital Management LLC now owns 929,004 shares of the company's stock valued at $11,076,000 after acquiring an additional 4,211 shares during the last quarter. Finally, Royce & Associates LP increased its position in Varex Imaging by 70.4% in the fourth quarter. Royce & Associates LP now owns 746,770 shares of the company's stock worth $10,895,000 after purchasing an additional 308,629 shares during the period.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.